![Urpo Lamminmäki profile picture](/sites/default/files/styles/profile_picture_horizontal/public/images/profile/836628.jpg?itok=BVkHNmfM)
Urpo
Lamminmäki
Professor, Biotechnology
InFLAMES Flagship
PhD
Areas of expertise
Antibody engineering
Bioaffinity assays
in vitro diagnostics
Teaching
Methods and application of molecular biotechnology
Antibody and protein engineering techniques
Protein chemistry
Diagnostics
Research
My research is largely focused to recombinant antibodies and other bioaffinity molecules. I am interested in developing techniques used for tailoring such molecules as well as applications of these molecules in various fields including diagnostics, drug development and biomarker discovery.
Publications
Tetraspanin immunoassay for the detection of extracellular vesicles and renal cell carcinoma (2024)
Nano select
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )
Lectins as potential tools for cancer biomarker discovery from extracellular vesicles (2023)
Biomarker research
(Vertaisarvioitu katsausartikkeli tieteellisessä aikakauslehdessä (A2))
Isolation and functional analysis of phage-displayed antibody fragments targeting the staphylococcal superantigen-like proteins (2023)
MicrobiologyOpen
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )
ImmunoPET Directed to the Brain: A New Tool for Preclinical and Clinical Neuroscience (2023)
Biomolecules
(A2 Vertaisarvioitu katsausartikkeli tieteellisessä lehdessä)
RECOMBINANT ANTIBODIES AGAINST ANATOXIN: A CYANOBACTERIAL NEUROTOXIN (2023)
WorldLab - EuroMedLab, Clinical Chemistry and Laboratory Medicine
(O2 Muu julkaisu )
Genotyped functional screening of soluble Fab clones enables in-depth analysis of mutation effects (2023)
Scientific Reports
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))
Selection of biophysically favorable antibody variants using a modified Flp-In CHO mammalian display platform (2023)
Frontiers in Bioengineering and Biotechnology
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))
Isolation and characterization of phage display-derived scFv antibodies against human parechovirus 1 VP0 protein (2022)
Scientific Reports
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))
Generation of a Large Repertoire of Monoclonal Antibodies against Dengue Virus NS1 Antigen and the Development of a Novel NS1 Detection Enzyme-Linked Immunosorbent Assay (2022)
Journal of Immunology
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))
Time-resolved fluorescence based direct two-site apoA-I immunoassays and their clinical application in patients with suspected obstructive coronary artery disease (2022)
Frontiers in Cardiovascular Medicine
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))